Pura Vida Investments’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-256,800
Closed -$5.36M 300
2021
Q1
$5.36M Buy
256,800
+156,800
+157% +$3.62M 0.15% 117
2020
Q4
$2.29M Buy
+100,000
New +$1.9M 0.08% 140
2020
Q3
Sell
-102,000
Closed -$1.38M 187
2020
Q2
$1.38M Buy
+102,000
New +$1.19M 0.13% 96
2020
Q1
Sell
-654,000
Closed -$16.3M 139
2019
Q4
$16.3M Sell
654,000
-121,000
-16% -$2.45M 1.43% 23
2019
Q3
$13.2M Buy
775,000
+575,000
+288% +$10.5M 2.25% 15
2019
Q2
$4.55M Buy
200,000
+100,000
+100% +$2.7M 0.69% 51
2019
Q1
$3.21M Buy
+100,000
New +$3.09M 0.46% 62
2018
Q4
Sell
-200,000
Closed -$5.75M 126
2018
Q3
$5.75M Buy
+200,000
New +$6.01M 1.21% 23
2017
Q3
Sell
-4,500
Closed -$126K 97
2017
Q2
$126K Buy
+4,500
New +$102K 0.05% 65
2017
Q1
Sell
-3,000
Closed -$645K 96
2016
Q4
$645K Buy
+3,000
New +$38.8K 0.24% 59
2016
Q3
Sell
-100,000
Closed -$1.29M 103
2016
Q2
$1.29M Buy
+100,000
New +$1.57M 0.55% 58

Other funds holding XENT

Pura Vida Investments's XENT Position: Q3 2021 in Review

Pura Vida Investments sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 531,229 shares — an estimated $9.08M sold.

Pura Vida Investments first reported a position in XENT in Q4 2015 and held it in 21 quarters. The position peaked at $19.6M in Q4 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Pura Vida Investments reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 531,229 Intersect ENT, Inc shares in Q3 2021, an estimated $9.08M.
  • Pura Vida Investments first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 21 quarters.
  • Pura Vida Investments's Intersect ENT, Inc position peaked at $19.6M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.